Thus, our first objective was to create and analyze sets of genes encoding products involved in interactions with PID gene products with varying degrees of confidence to then assess the cumulative effect of rare HI variants in these genes in severe COVID-19. The gene discussed is MTA2; the disease is COVID-19.